The Risk of Cardiovascular Disease, Diabetes, Liver-Related Outcomes, and Death Over 10 Years in HIV/HCV-Coinfected Patients With and Without Steatosis.

@article{Down2016TheRO,
  title={The Risk of Cardiovascular Disease, Diabetes, Liver-Related Outcomes, and Death Over 10 Years in HIV/HCV-Coinfected Patients With and Without Steatosis.},
  author={Carrie Down and Natasha Mehta and Kristen M Marks},
  journal={AIDS research and human retroviruses},
  year={2016},
  volume={32 9},
  pages={868-71}
}
BACKGROUND Coinfection with HIV/HCV is associated with more severe liver disease, including increased frequency of steatosis and significant fibrosis, compared to patients mono-infected with HCV or HIV. We sought to explore the impact of steatosis on cardiovascular disease (CVD), liver-related outcomes, and survival. METHODS An IRB-approved, single-center… CONTINUE READING